Recent advances and application of generative adversarial networks in drug discovery, development, and targeting
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
A rising amount of research demonstrates that artificial intelligence and machine learning approaches can provide an essential basis for the drug design and discovery process. Deep learning algorithms are being developed in response to recent advances in computer technology as part of the creation of therapeutically relevant medications for the treatment of a variety of ailments. In this review, we focus on the most recent advances in the areas of drug design and discovery research employing generative deep learning methodologies such as generative adversarial network (GAN) frameworks. To begin, we examine drug design and discovery studies that use several GAN methodologies to evaluate one key application, such as molecular de novo design in drug design and discovery. Furthermore, we discuss many GAN models for dimension reduction of single-cell data at the preclinical stage of the drug development pipeline. We also show various experiments in de novo peptide and protein creation utilizing GAN frameworks. Furthermore, we discuss the limits of past drug design and discovery research employing GAN models. Finally, we give a discussion on future research prospects and obstacles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Gradient-based learning applied to document recognition
Lecun, Y., Bottou, L., Bengio, Y., & Haffner, P. (1998) · Proceedings of the IEEE · doi:10.1109/5.726791 · Cited by 58,805
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
The perceptron: A probabilistic model for information storage and organization in the brain.
Rosenblatt, F. (1958) · Psychological Review · doi:10.1037/h0042519 · Cited by 12,280
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Improved training of Wasserstein GANs
Gulrajani, I., Ahmed, F., Arjovsky, M., Dumoulin, V., & Courville, A. (2017) · arXiv · doi:10.48550/arxiv.1704.00028 · Cited by 6,800
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436
A guide to deep learning in healthcare
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S., & Dean, J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0316-z · Cited by 5,312
Machine learning for molecular and materials science
Butler, K. T., Davies, D. W., Cartwright, H., Isayev, O., & Walsh, A. (2018) · Nature · doi:10.1038/s41586-018-0337-2 · Cited by 4,968
Research works printed but not linked: 96
- Hessler, 2018, Artificial intelligence in drug design, Molecules, 23, 2520, 10.3390/molecules23102520 · DOI · Paper page
- Jing, 2018, Deep learning for drug design: an artificial intelligence paradigm for drug discovery in the big data era, AAPS J, 20, 1, 10.1208/s12248-018-0210-0 · DOI · Paper page
- Rifaioglu, 2019, Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases, Brief Bioinformatics, 20, 1878, 10.1093/bib/bby061 · DOI · Paper page
- Ekins, 2016, The next era: deep learning in pharmaceutical research, Pharm Res, 33, 2594, 10.1007/s11095-016-2029-7 · DOI · Paper page
- Kingma D.P., Welling M.. Auto-encoding variational bayes. arXiv preprint arXiv:131261142013;.
- Wang, 2018, Vasc: dimension reduction and visualization of single-cell rna-seq data by deep variational autoencoder, Genomics Proteomic Bioinform, 16, 320, 10.1016/j.gpb.2018.08.003 · DOI · Paper page
- Ghasemi, 2018, Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks, Drug Discov Today, 23, 1784, 10.1016/j.drudis.2018.06.016 · DOI · Paper page
- Ching, 2018, Opportunities and obstacles for deep learning in biology and medicine, J R Soc Interface, 15, 20170387, 10.1098/rsif.2017.0387 · DOI · Paper page
- Dana, 2018, Deep learning in drug discovery and medicine; scratching the surface, Molecules, 23, 2384, 10.3390/molecules23092384 · DOI · Paper page
- Lin, 2018, A deep learning approach for predicting antidepressant response in major depression using clinical and genetic biomarkers, Front Psychiatry, 9, 290, 10.3389/fpsyt.2018.00290 · DOI · Paper page
- Goodfellow, 2014, Generative adversarial nets, Adv Neural Inf Process Syst, 27
- Zhao, 2018, Synthesizing retinal and neuronal images with generative adversarial nets, Med Image Anal, 49, 14, 10.1016/j.media.2018.07.001 · DOI · Paper page
- Hu, 2018, Unsupervised learning for cell-level visual representation in histopathology images with generative adversarial networks, IEEE J Biomed Health Inform, 23, 1316, 10.1109/JBHI.2018.2852639 · DOI · Paper page
- Mardani, 2018, Deep generative adversarial neural networks for compressive sensing MRI, IEEE Trans Med Imaging, 38, 167, 10.1109/TMI.2018.2858752 · DOI · Paper page
- Lin, 2020, A deep adversarial variational autoencoder model for dimensionality reduction in single-cell RNA sequencing analysis, BMC Bioinformatics, 21, 1, 10.1186/s12859-020-3401-5 · DOI
- Alqahtani, 2021, Applications of generative adversarial networks (GANs): an updated review, Arch Comput Methods Eng, 28, 525, 10.1007/s11831-019-09388-y · DOI · Paper page
- Mirza M., Osindero S.. Conditional generative adversarial nets. arXiv preprint arXiv:141117842014a;.
- Makhzani A., Shlens J., Jaitly N., Goodfellow I., Frey B.. Adversarial autoencoders. arXiv preprint arXiv:1511056442015;.
- Guimaraes G.L., Sanchez-Lengeling B., Outeiral C., Farias P.L.C., Aspuru-Guzik A.. Objective-reinforced generative adversarial networks (ORGAN) for sequence generation models. arXiv preprint arXiv:170510843
- Sanchez-Lengeling B., Outeiral C., Guimaraes G.L., Aspuru-Guzik A.. Optimizing distributions over molecular space. an objective-reinforced generative adversarial network for inverse-design chemistry (ORGANIC)2017a;. · DOI · Paper page
- Putin, 2018, Reinforced adversarial neural computer for de novo molecular design, J Chem Inf Model, 58, 1194, 10.1021/acs.jcim.7b00690 · DOI · Paper page
- Putin, 2018, Adversarial threshold neural computer for molecular de novo design, Mol Pharm, 15, 4386, 10.1021/acs.molpharmaceut.7b01137 · DOI · Paper page
- Prykhodko, 2019, A de novo molecular generation method using latent vector based generative adversarial network, J Cheminform, 11, 1, 10.1186/s13321-019-0397-9 · DOI · Paper page
- Aha D.W. Kibler D. Albert M.K.. Instance-based learning algorithms1991;. · DOI · Paper page
- Barlow, 1989, Unsupervised learning, Neural Comput, 1, 295, 10.1162/neco.1989.1.3.295 · DOI · Paper page
- Kaelbling, 1996, Reinforcement learning: a survey, CoRR
- LeCun, 2015, Deep learning, Nature, 521, 436, 10.1038/nature14539 · DOI · Paper page
- Geoghegan, 2020, Orientalism and informatics: alterity from the chess-playing turk to Amazon’s mechanical turk, Ex-position, 45
- Goodfellow, 2014, Generative adversarial nets, vol. 27
- Johnson, 2016, Google’s multilingual neural machine translation system: enabling zero-shot translation, CoRR
- Ng, 2001, On discriminative vs. generative classifiers: a comparison of logistic regression and naive bayes, vol. 14
- Mirza, 2014, Conditional generative adversarial nets, CoRR
- Denton, 2015, Deep generative image models using a laplacian pyramid of adversarial networks, CoRR
- Radford A., Metz L., Chintala S.. Unsupervised representation learning with deep convolutional generative adversarial networks. arXiv preprint arXiv:1511064342015;.
- Chen, 2016, InfoGAN: interpretable representation learning by information maximizing generative adversarial nets, CoRR
- Vaswani, 2017, Attention is all you need, CoRR
- Méndez-Lucio, 2020, De novo generation of hit-like molecules from gene expression signatures using artificial intelligence, Nat Commun, 11, 1, 10.1038/s41467-019-13807-w · DOI · Paper page
- Lipton, 2015, A critical review of recurrent neural networks for sequence learning, arXiv preprint arXiv:150600019
- Martinez-Mayorga, 2020, The impact of chemoinformatics on drug discovery in the pharmaceutical industry, Expert Opin Drug Discov, 15, 293, 10.1080/17460441.2020.1696307 · DOI
- Weininger, 1988, Smiles, a chemical language and information system. 1. Introduction to methodology and encoding rules, J Chem Inf Comput Sci, 28, 31, 10.1021/ci00057a005 · DOI · Paper page
- Yin W., Fu Y., Sigal L., Xue X.. Semi-latent GAN: learning to generate and modify facial images from attributes. arXiv preprint arXiv:1704021662017.
- Wang, 2018, Beyond low-rank representations: orthogonal clustering basis reconstruction with optimized graph structure for multi-view spectral clustering, Neural Netw, 103, 1, 10.1016/j.neunet.2018.03.006 · DOI
- Liu, 2016, Coupled generative adversarial networks, Adv Neural Inf Process Syst, 29
- Xue, 2018, SegAN: adversarial network with multi-scale l1 loss for medical image segmentation, Neuroinformatics, 16, 383, 10.1007/s12021-018-9377-x · DOI · Paper page
- Bjerrum, 2018, Improving chemical autoencoder latent space and molecular de novo generation diversity with heteroencoders, Biomolecules, 8, 131, 10.3390/biom8040131 · DOI · Paper page
- Zhou S., Xiao T., Yang Y., Feng D., He Q., He W.. GeneGAN: learning object transfiguration and attribute subspace from unpaired data. arXiv preprint arXiv:1705049322017.
- Liu J., Li W., Pei H., Wang Y., Qu F., Qu Y., Chen Y.. Identity preserving generative adversarial network for cross-domain person re-identification. IEEE Access2019; 7:114021–114032. · DOI
- Vondrick, 2016, Generating videos with scene dynamics, Adv Neural Inf Process Syst, 29
- Zhou S.-F., Zhong W.-Z.. Drug design and discovery: principles and applications. 2017. · DOI
- Goh G.B., Siegel C., Vishnu A., Hodas N.O., Baker N.. Chemception: a deep neural network with minimal chemistry knowledge matches the performance of expert-developed QSAR/QSPR models. arXiv preprint arXiv:1706066892017b;.
- You, 2018, Graph convolutional policy network for goal-directed molecular graph generation, Adv Neural Inf Process Syst, 31
- Durant, 2002, Reoptimization of MDL keys for use in drug discovery, J Chem Inf Comput Sci, 42, 1273, 10.1021/ci010132r · DOI · Paper page
- Blanchard, 2021, Using GANs with adaptive training data to search for new molecules, J Cheminform, 13, 1, 10.1186/s13321-021-00494-3 · DOI · Paper page
- Lin, 2020, Relevant applications of generative adversarial networks in drug design and discovery: molecular de novo design, dimensionality reduction, and de novo peptide and protein design, Molecules, 25, 3250, 10.3390/molecules25143250 · DOI · Paper page
- Mouchlis, 2021, Advances in de novo drug design: from conventional to machine learning methods, Int J Mol Sci, 22, 1676, 10.3390/ijms22041676 · DOI · Paper page
- Sabban S., Markovsky M.. RamaNet: computational de novo helical protein backbone design using a long short-term memory generative adversarial neural network [version 1; peer review: 1 not]2020;. · doi:10.1101/671552
- Karimi, 2019, De novo protein design for novel folds using guided conditional wasserstein generative adversarial networks (gcWGAN), bioRxiv, 769919
- Anand, 2018, Generative modeling for protein structures, Adv Neural Inf Process Syst, 31
- Bian, 2019, Deep convolutional generative adversarial network (dcGAN) models for screening and design of small molecules targeting cannabinoid receptors, Mol Pharm, 16, 4451, 10.1021/acs.molpharmaceut.9b00500 · DOI
- Gupta A., Zou J.. Feedback GAN (FBGAN) for DNA: a novel feedback-loop architecture for optimizing protein functions. arXiv preprint arXiv:1804016942018;.
- Guimaraes G.L., Sanchez-Lengeling B., Outeiral C., Farias P.L.C., Aspuru-Guzik A.. Objective-reinforced generative adversarial networks (ORGAN) for sequence generation models. arXiv preprint arXiv:170510843
- Zhao, 2020, GANsDTA: predicting drug-target binding affinity using GANs, Front Genet, 1243, 10.3389/fgene.2019.01243 · DOI · Paper page
- Chen, 2018, The rise of deep learning in drug discovery, Drug Discov Today, 23, 1241, 10.1016/j.drudis.2018.01.039 · DOI · Paper page
- Zhavoronkov A.. Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry. 2018. · DOI · Paper page
- Sanchez-Lengeling, 2018, Inverse molecular design using machine learning: generative models for matter engineering, Science, 361, 360, 10.1126/science.aat2663 · DOI · Paper page
- Kuhn, 2016, A real-world perspective on molecular design: miniperspective, J Med Chem, 59, 4087, 10.1021/acs.jmedchem.5b01875 · DOI
- Torchilin, 2000, Drug targeting, Eur J Pharm Sci, 11, S81, 10.1016/S0928-0987(00)00166-4 · DOI · Paper page
- Mukherjee S., Ghosh M., Basuchowdhuri P.. Deep graph convolutional network and LSTM based approach for predicting drug-target binding affinity. arXiv preprint arXiv:2201068722022;.
- Polykovskiy, 2018, Entangled conditional adversarial autoencoder for de novo drug discovery, Mol Pharm, 15, 4398, 10.1021/acs.molpharmaceut.8b00839 · DOI · Paper page
- Prykhodko, 2019, A de novo molecular generation method using latent vector based generative adversarial network, J Cheminform, 11, 1, 10.1186/s13321-019-0397-9 · DOI · Paper page
- Kadurin, 2017, The cornucopia of meaningful leads: applying deep adversarial autoencoders for new molecule development in oncology, Oncotarget, 8, 10883, 10.18632/oncotarget.14073 · DOI · Paper page
- Kadurin, 2017, DruGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico, Mol Pharm, 14, 3098, 10.1021/acs.molpharmaceut.7b00346 · DOI · Paper page
- Sanchez-Lengeling B., Outeiral C., Guimaraes G.L., Aspuru-Guzik A.. Optimizing distributions over molecular space. an objective-reinforced generative adversarial network for inverse-design chemistry (ORGANIC)2017b;. · DOI · Paper page
- Putin, 2018, Reinforced adversarial neural computer for de novo molecular design, J Chem Inf Model, 58, 1194, 10.1021/acs.jcim.7b00690 · DOI · Paper page
- Weininger, 1988, Smiles, a chemical language and information system. 1. Introduction to methodology and encoding rules, J Chem Inf Comput Sci, 28, 31, 10.1021/ci00057a005 · DOI · Paper page
- Heller, 2015, InChi, the IUPAC international chemical identifier, J Cheminform, 7, 1, 10.1186/s13321-015-0068-4 · DOI · Paper page
- Durant, 2002, Reoptimization of MDL keys for use in drug discovery, J Chem Inf Comput Sci, 42, 1273, 10.1021/ci010132r · DOI · Paper page
- Rogers, 2010, Extended-connectivity fingerprints, J Chem Inf Model, 50, 742, 10.1021/ci100050t · DOI · Paper page
- Glen, 2006, Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME, IDrugs, 9, 199
- Hert, 2004, Comparison of fingerprint-based methods for virtual screening using multiple bioactive reference structures, J Chem Inf Comput Sci, 44, 1177, 10.1021/ci034231b · DOI · Paper page
- Pérez-Nueno, 2009, APIF: a new interaction fingerprint based on atom pairs and its application to virtual screening, J Chem Inf Model, 49, 1245, 10.1021/ci900043r · DOI · Paper page
- Apweiler, 2004, UniProt: the universal protein knowledgebase, Nucleic Acids Res, 32, D115, 10.1093/nar/gkh131 · DOI · Paper page
- Berman, 2000, The protein data bank, Nucleic Acids Res, 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
- Gaulton, 2017, The chEMBL database in 2017, Nucleic Acids Res, 45, D945, 10.1093/nar/gkw1074 · DOI · Paper page
- Papadatos, 2016, SurechEMBL: a large-scale, chemically annotated patent document database, Nucleic Acids Res, 44, D1220, 10.1093/nar/gkv1253 · DOI · Paper page
- Gilson, 2016, BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology, Nucleic Acids Res, 44, D1045, 10.1093/nar/gkv1072 · DOI · Paper page
- Huang, 2014, ASD v2. 0: updated content and novel features focusing on allosteric regulation, Nucleic Acids Res, 42, D510, 10.1093/nar/gkt1247 · DOI · Paper page
- O’Boyle, 2011, Open babel: an open chemical toolbox, J Cheminform, 3, 1
- Willighagen, 2017, The chemistry development kit (CDK) v2. 0: atom typing, depiction, molecular formulas, and substructure searching, J Cheminform, 9, 1
- Al-Rfou, 2016, Theano: a python framework for fast computation of mathematical expressions, arXiv e-prints, 1605
- Paszke, 2019, Pytorch: an imperative style, high-performance deep learning library, Adv Neural Inf Process Syst, 32
- Pedregosa, 2011, Scikit-learn: machine learning in python, J Mach Learn Res, 12, 2825
- Norgeot, 2019, A call for deep-learning healthcare, Nat Med, 25, 14, 10.1038/s41591-018-0320-3 · DOI · Paper page
- Yang, 2018, Clinical assistant diagnosis for electronic medical record based on convolutional neural network, Sci Rep, 8, 1
- Gkotsis, 2017, Characterisation of mental health conditions in social media using informed deep learning, Sci Rep, 7, 1
- Koscielny, 2010, Why most gene expression signatures of tumors have not been useful in the clinic, Sci Transl Med, 2, 10.1126/scitranslmed.3000313 · DOI · Paper page
Cited by
Visan, A. I., & Negut, I. (2024) · Life · doi:10.3390/life14020233 · Cited by 279
Unleashing the power of generative AI in drug discovery
Gangwal, A., & Lavecchia, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103992 · Cited by 195
Visual Deepfake Detection: Review of Techniques, Tools, Limitations, and Future Prospects
Ur Rehman Ahmed, N., Badshah, A., Adeel, H., Tajammul, A., Daud, A., & Alsahfi, T. (2025) · IEEE Access · doi:10.1109/access.2024.3523288 · Cited by 45
Dai, J., Zhang, Y., Shi, C., Liu, Y., Xiu, P., & Wang, Y. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c06729 · Cited by 3
Metadata
- Authors
- Tripathi, S., Augustin, A. I., Dunlop, A., Sukumaran, R., Dheer, S., Zavalny, A., Haslam, O., Austin, T., Donchez, J., Tripathi, P. K., & Kim, E.
- Venue
- Artificial Intelligence in the Life Sciences
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 2
- Pages
- 100045
- ISSN
- 2667-3185 (ISSN-L)
- OpenAlex
- W4308043267
- Cited by
- 59
- References
- 40
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent advances and application of generative adversarial networks in drug discovery, development, and targeting. https://app.cochat.ai/papers/10.1016/j.ailsci.2022.100045
- The paper
- Tripathi, S., Augustin, A. I., Dunlop, A., Sukumaran, R., Dheer, S., Zavalny, A., Haslam, O., Austin, T., Donchez, J., Tripathi, P. K., & Kim, E. (2022). Recent advances and application of generative adversarial networks in drug discovery, development, and targeting. Artificial Intelligence in the Life Sciences. https://doi.org/10.1016/j.ailsci.2022.100045
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.